5-fluorouracil steady state pharmacokinetics and outcome in patients receiving protracted venous infusion for advanced colorectal cancer

PVI 5FU gives increased response rates and reduced toxicity when compared to bolus 5FU (J Clin Oncol 1989, 425–432). PVI 5FU administration was reported to give highly variable (>1000-fold) plasma 5FU concentrations at steady state (FU Css) which correlated with toxicity (Ann Oncol 1996, 47–53);...

Descripción completa

Detalles Bibliográficos
Autores principales: Jodrell, D I, Stewart, M, Aird, R, Knowles, G, Bowman, A, Wall, L, Cummings, J, McLean, C
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2001
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363784/
https://www.ncbi.nlm.nih.gov/pubmed/11237378
http://dx.doi.org/10.1054/bjoc.2000.1664

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2363784/
https://www.ncbi.nlm.nih.gov/pubmed/11237378
http://dx.doi.org/10.1054/bjoc.2000.1664

Ejemplares similares